Endovascular navigation with Fiber Optic RealShape technology.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
01 2023
Historique:
received: 28 03 2022
revised: 20 07 2022
accepted: 03 08 2022
pubmed: 14 8 2022
medline: 27 12 2022
entrez: 13 8 2022
Statut: ppublish

Résumé

Fiber Optic RealShape (FORS) technology has recently been introduced as an adjunctive guidance technology that allows real-time three-dimensional visualization of dedicated endovascular devices while avoiding radiation exposure. It consists of equipment which sends pulses of light through hair-thin optical fibers that run within a dedicated hydrophilic wire and selective catheters. The purpose of the study was to report the observed benefits and limitations related to the first edition of FORS technology. Data were collected prospectively from the first 50 patients undergoing FORS-guided endovascular repair at a single center between February 2020 and February 2021 as part of the global multicenter FORS Learn registry. All consecutive, elective procedures with one or more navigation tasks attempted with FORS were included. Factors related to FORS navigation task success were assessed. The time required for the catheterization of each task as well as the amount of radiation exposure (fluoroscopy time, dose area product, and estimated skin dose) were collected. A per-task analysis was conducted. End points included the success rate in achieving a stable FORS-guided catheterization, catheterization time, and radiation dose during catheterization. During the study period from February 2020 to February 2021, 50 patients were treated using FORS technology. Forty-five patients were treated for aortic aneurysm, 4 for iliac artery aneurysm, and 1 for splenic artery aneurysm. Overall, 201 navigation tasks were completed for these procedures and FORS was used in 186 tasks (92.5%). No FORS-related complication was recorded and a success rate of 60.2% (n = 116) was observed. Target vessel (TV) angle of 45° or greater, TV stenosis, and the renal arteries as navigation tasks (compared with celiac artery or superior mesenteric artery) were associated with a lower success rate. Catheterization of a TV through a branch more frequently required a standard catheter in combination with the FORS-enabled guidewire. Successful task catheterization using FORS guidance was associated with a shorter catheterization time 6 minutes (interquartile range, 3-11 minutes) versus 16 minutes (interquartile range, 10-24 minutes) (P < .001) and lower radiation exposure compared with unsuccessful catheterization (dose area product, 4.4 cGy/cm FORS technology was implemented successfully as a new guidance technology in a complex endovascular aortic repair program and was associated with an encouraging success rate and a high potential for radiation reduction.

Identifiants

pubmed: 35963458
pii: S0741-5214(22)02116-4
doi: 10.1016/j.jvs.2022.08.002
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-8.e2

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Giuseppe Panuccio (G)

German Aortic Center Hamburg, Department of Vascular Medicine, University hospital Eppendorf UKE, Hamburg, Germany. Electronic address: giuseppe.panuccio@gmail.com.

Andres Schanzer (A)

Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, MA.

Fiona Rohlffs (F)

German Aortic Center Hamburg, Department of Vascular Medicine, University hospital Eppendorf UKE, Hamburg, Germany.

Franziska Heidemann (F)

German Aortic Center Hamburg, Department of Vascular Medicine, University hospital Eppendorf UKE, Hamburg, Germany.

Bart Wessels (B)

Philips Medical Systems Nederland, Best, The Netherlands.

Geert W Schurink (GW)

Department of Vascular Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.

Joost A van Herwaarden (JA)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Tilo Kölbel (T)

German Aortic Center Hamburg, Department of Vascular Medicine, University hospital Eppendorf UKE, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH